Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy

BACKGROUND: Proprotein convertase subtilisin/kexin 9 (PCSK9) has been proposed as a novel target for coronary artery disease (CAD). Familial hypercholesterolemia (FH) is characterized by high prevalence of CAD and major cardiovascular events (MACEs). However, no data is available on the association...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Transl Med
Main Authors: Cao, Ye-Xuan, Jin, Jing-Lu, Sun, Di, Liu, Hui-Hui, Guo, Yuan-Lin, Wu, Na-Qiong, Xu, Rui-Xia, Zhu, Cheng-Gang, Dong, Qian, Sun, Jing, Li, Jian-Jun
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6849213/
https://ncbi.nlm.nih.gov/pubmed/31711505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-019-2123-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados